Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haplo-cord HCT vs Haplo-HCT for T-ALL
NCT06381817Phase 3Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Apr 2024
- Primary completion
- Mar 2028
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of umbilical cord blood in t-cell acute lymphoblastic leukemia (T-ALL), sponsored by First Affiliated Hospital of Soochow University. Started Apr 2024; status: recruiting.
02
Drugs
umbilical cord blood
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)
Beyond the preview
Go deeper on NCT06381817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381817.